References :
[1] Tidyman WE, Rauen KA. Noonan, Costello and cardiofacio-cutaneous syndromes: dysregulation of the RasMAPK pathway. Expert Rev Mol Med. 2008; 10:e37.
[2] Tidyman WE, Rauen KA. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.Curr Opin Genet Dev. 2009; 19:230–6.
[3] Niihori T, Aoki Y, Narumi Y, et al. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.Nat Genet. 2006; 38:294–6.
[4]... More
[1] Tidyman WE, Rauen KA. Noonan, Costello and cardiofacio-cutaneous syndromes: dysregulation of the RasMAPK pathway. Expert Rev Mol Med. 2008; 10:e37.
[2] Tidyman WE, Rauen KA. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.Curr Opin Genet Dev. 2009; 19:230–6.
[3] Niihori T, Aoki Y, Narumi Y, et al. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.Nat Genet. 2006; 38:294–6.
[4] Rodriguez-Viciana P, Tetsu O, Tidyman WE, et al. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science. 2006; 311: 287–90.
[5] Roberts AE, Allanson J, Jadico SK, Kavamura MI, Noonan J, Opitz JM, et al. The cardiofaciocutaneous syndrome. J Med Genet. 2006;43:833-42.
[6] Narumi Y, Aoki Y, Niihori T, Neri G, Cavé H, Verloes A, et al. Molecular and clinical characterization of cardio-facio-cutaneous (CFC) syndrome: Overlapping clinical manifestations with Costello syndrome. Am J Med Genet Part A 2007; 143A:799-807.
[7] Roberts AE. The clinical phenotype of cardiofaciocutaneous syndrome; in Zenker M (Ed): Noonan Syndrome and related disorders- A Matter of Deregulated Ras Signaling. Monogr Hum Gent Basel, Karger, 2009, vol 17, pp 66-72.
[8] Roberts A, Allanson J, Jadico SK, et al. The cardiofaciocutaneous syndrome. J Med Genet. 2006; 43(11):833-42.
[9] Weston G, Payette M. Update on lichen planus and its clinical variants. Int J Womens Dermatol. 2015; 1(3):140–149. doi:10.1016/j.ijwd.2015.04.001
[10]Boyd AS, Neldner KH. Lichen planus. J. Am. Acad. Dermatol. 1991 Oct; 25(4):593-619
[11] Wagner G., Rose C., Sachse M.M. Clinical variants of lichen planus. J Dtsch Dermatol Ges. 2013; 11(4):309– 319.
[12]Gorouhi F, Davari P, Fazel N. Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. ScientificWorldJournal. 2014; 2014:742826. doi:10.1155/2014/742826.
[13] Le Cleach L, Chosidow O. Clinical practice. Lichen planus. N. Engl. J. Med. 2012 Feb 23; 366(8):723-32
[14] Aghbari SMH, Abushouk AI, Attia A, Elmaraezy A, Menshawy A, Ahmed MS, Elsaadany BA, Ahmed EM. Malignant transformation of oral lichen planus and oral lichenoid lesions: A meta-analysis of 20095 patient data. Oral Oncol. 2017 May; 68:92-102. Doi: 10.1016/j.oraloncology.2017.03.012.
[15]Richards D1. Malignant transformation rates in Oral Lichen Planus. Evid Based Dent. 2018 Dec; 19(4):122. Doi: 10.1038/sj.ebd.6401349.... Less